Logo Logo
Switch Language to German

Niculescu, Luana; Rothenberger, Christoph; Pinarci, Melda; Peric, Jelena; Alharbi, Rehab and Wollenberg, Andreas (2016): New Perspectives in the Treatment of Atopic Dermatitis in the Pediatric Population. In: Pediatric Allergy Immunology and Pulmonology, Vol. 29, No. 4: pp. 189-195

Full text not available from 'Open Access LMU'.


Treatment of children diagnosed with atopic dermatitis (AD) is an art. Age-dependent barrier function, skin physiology, body surface: weight ratio, the compliance of patient and caregivers, and legal considerations related to the license status of topical and systemic drugs must be considered. Mild to moderate AD can usually be treated sufficiently with a personalized regimen of emollients and topical anti-inflammatory therapy consisting of topical corticosteroids (TCSs) or topical calcineurin inhibitors. Emollients containing bacterial lysates, tailored wet wrap regimen, and proactive therapy with tacrolimus ointment or some TCSs are new developments in the field. Severe ADmay need systemic therapy, but all currently available systemic agents for severeADare either not licensed for children or not advisable on the long term, or both. Therapeutic patient education based on structured, interactive sessions with patients or caregivers and a multidisciplinary team is highly effective. This publication summarizes the current therapeutic options used in the pediatric AD population.

Actions (login required)

View Item View Item